WHO WE ARE

홈으로화살표WHAT WE DO 화살표 R&D

R&D

To become a global leader in the dental healthcare
R&D 이미지
We developed HysensBio Co., Ltd. was established in 2016 based on the result of basic and clinical research of dentistry for last 20 years. In our regenerative dental medicine R&D center, dentists and dental science researchers are cooperating with many expert groups from Seoul National University(SNU) and SNU Dental Hospital.
치주진단 바이오마커 개발, 치주조직 재생기술 개발, 시린이 치료기술 개발, 치아상아질 재생기술 개발, 치아줄기세포유래 단백질활용기술개발
Developed the world's first dentin regeneration technology
We discovered that CPNE7 protein induces dentin formation. The physiological dentin regeneration was confirmed in vivo. We have developed functional peptides that shows the same function as CPNE7 protein. And we have applied for a patent for these peptides in 12 countries. Based on this technology, we are developing novel peptide medicine to treat dental caries and dentin hypersensitivity.

비글견 치아우식증 모델의 펩타이드 효능시험 결과, 기능성 펩타이드의 특허출원국 현황